Perryman Financial Advisory’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Perryman Financial Advisory's LLY Position: Q2 2026 in Review
Perryman Financial Advisory increased its Eli Lilly (LLY) stake by 21% in Q2 2026, buying an estimated $418K and bringing the position to 2,398 shares worth $2.88M. The position accounts for 0.38% of the portfolio, ranked #59.
Perryman Financial Advisory first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 2,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Perryman Financial Advisory held 2,398 shares of Eli Lilly worth $2.88M as of Q2 2026.
- Perryman Financial Advisory bought 409 Eli Lilly shares in Q2 2026, an estimated $418K.
- Eli Lilly made up 0.38% of Perryman Financial Advisory's portfolio in Q2 2026, its #59 holding.
- Perryman Financial Advisory first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
- 2,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Perryman Financial Advisory's 13F filing for Q2 2026, filed 24 Jul 2026.